Table 2. Units of Resources Required To Manage CMPA and its Allergic Manifestations*.
Resource | Year 1 | Year 2 | Year 3 |
---|---|---|---|
Management of CMPA/Urticaria | |||
GP visits (mean per patient) | 8 | 3 | 2 |
General paediatrician visits (mean per patient) | 1 | 1 | 1 |
Paediatric allergist visits (mean per patient) | 0.84 | 0.84 | 0.84 |
Dietitian visits (mean per patient) | 2.8 | 1.64 | 1.64 |
Accident & emergency attendances (mean per patient) | 0.3 | 0.3 | 0 |
Hospital admissions (mean per patient) | 0.08 | 0.05 | 0.03 |
Percentage referred to a general paediatrician | 50% | 0% | 0% |
Percentage referred to a paediatric allergist | 40% | 0% | 0% |
Percentage referred to a dietitian | 90% | 0% | 0% |
Percentage prescribed H2 antagonists or proton pump inhibitors | 28% | 0% | 0% |
Percentage prescribed emollients | 85% | 0% | 0% |
Percentage prescribed systemic corticosteroids | 3% | 3% | 3% |
Percentage prescribed topical corticosteroids | 50% | 50% | 50% |
Percentage prescribed antihistamines | 60% | 60% | 60% |
Management of Eczema | |||
GP visits (mean per patient) | 4 | 3 | 3 |
General paediatrician visits (mean per patient) | 0.9 | 0.9 | 0.9 |
Paediatric dermatologist visits (mean per patient) | 0.03 | 0.06 | 0.06 |
Accident & emergency attendances (mean per patient) | 0.13 | 0.13 | 0.13 |
Hospital admissions (mean per patient) | 0.03 | 0.03 | 0.03 |
Percentage referred to a general paediatrician | 45% | 0% | 0% |
Percentage referred to a dermatologist | 3% | 0% | 0% |
Percentage prescribed emollients | 100% | 100% | 100% |
Percentage prescribed topical corticosteroids | 70% | 70% | 70% |
Percentage prescribed antihistamines | 50% | 50% | 50% |
Management of Asthma | |||
GP visits (mean per patient) | 7 | 6 | 5 |
General paediatrician visits (mean per patient) | 2 | 0.9 | 0.9 |
Accident & emergency attendances (mean per patient) | 0.2 | 0.2 | 0.2 |
Hospital admissions (mean per patient) | 0.4 | 0.4 | 0.4 |
Percentage referred to a general paediatrician | 65% | 0% | 0% |
Percentage prescribed systemic corticosteroids | 40% | 0% | 0% |
Percentage prescribed Ventolin/beta agonists | 100% | 100% | 100% |
Percentage prescribed inhaled corticosteroids | 55% | 55% | 55% |
Management of Rhinoconjunctivitis | |||
GP visits (mean per patient) | 2 | 2 | 2 |
General paediatrician visits (mean per patient) | 0.1 | 0 | 0 |
Accident & emergency attendances (mean per patient) | 0.03 | 0 | 0 |
Percentage referred to a general paediatrician | 5% | 0% | 0% |
Percentage prescribed antihistamines | 80% | 80% | 80% |
Assumptions on Diagnostic Tests | |||
Number of IgE blood tests | 2 | 1 | 1 |
Proportion of children | 100% | 100% | 100% |
Mean Number of Prescriptions per Patient | |||
Weekly prescription for proton pump inhibitors | 3.8 | 3.8 | 3.8 |
Monthly prescription for emollients | 3.3 | 3.3 | 3.3 |
Weekly prescription for systemic corticosteroids | 0.9 | 0.9 | 0.9 |
Monthly prescription for topical corticosteroids | 1.1 | 1.1 | 1.1 |
Monthly prescription for antihistamines | 0.3 | 0.3 | 0.3 |
Monthly prescription for inhaled corticosteroids | 0.9 | 0.9 | 0.9 |
Monthly prescription of salbutamol 100 mcg/dose | 0.9 | 0.9 | 0.9 |
*Guest and Singh 2019
Abbreviations: CMPA, cow’s milk protein allergy; H2, histamine H2 receptors; IgE, immunoglobulin E.